Superagonist<-agonist<-partial agonist<-silent agonist->inverse agonist->antagonist.
Now, what defines a supeagonist is simple, but not so clear with patrial agonist as some make bind in two or more conformations making them mixed agonists. Same with inverse agonist, it just demonstrates more antagonism than agonism.
Always try to get the EC50 value of a ligand as this can be more illustrative but functional MRI and functional PET are the best tools we have to know where a ligand actually binds in such a complex system as the human body. Lopramide has a Ki of 3.15 nM ± 1.5 nM (similar to morphine) but doesn't cross the BBB well and an active transport removes it from the brain. So Ki can tell you only a little.
It's something to know, certainly, but you would be amazed at how much has to be inferred and how far out of one specific scallfold one may have to look to find a key moiety. That's why I asked about BDPC experiences - I wish to understand the docking and active conformations and a user report WOULD be of value to science. Not to me specifically, but because we cannot perform such tests legally - hence we are ignorance.